- Home
- AII vs MRVI Comparison
AII vs MRVI Comparison
Compare AII & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AII
- MRVI
- Stock Information
- Founded
- AII 2006
- MRVI 2014
- Country
- AII United States
- MRVI United States
- Employees
- AII N/A
- MRVI N/A
- Industry
- AII Property-Casualty Insurers
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- AII Finance
- MRVI Health Care
- Exchange
- AII Nasdaq
- MRVI Nasdaq
- Market Cap
- AII 370.5M
- MRVI 350.1M
- IPO Year
- AII 2025
- MRVI 2020
- Fundamental
- Price
- AII $19.96
- MRVI $2.42
- Analyst Decision
- AII Buy
- MRVI Hold
- Analyst Count
- AII 4
- MRVI 10
- Target Price
- AII $21.67
- MRVI $5.84
- AVG Volume (30 Days)
- AII 78.8K
- MRVI 1.5M
- Earning Date
- AII 08-12-2025
- MRVI 08-11-2025
- Dividend Yield
- AII N/A
- MRVI N/A
- EPS Growth
- AII N/A
- MRVI N/A
- EPS
- AII 60.71
- MRVI N/A
- Revenue
- AII $260,047,000.00
- MRVI $219,830,000.00
- Revenue This Year
- AII $25.82
- MRVI N/A
- Revenue Next Year
- AII $25.78
- MRVI $7.23
- P/E Ratio
- AII $0.33
- MRVI N/A
- Revenue Growth
- AII 1.73
- MRVI N/A
- 52 Week Low
- AII $15.78
- MRVI $1.67
- 52 Week High
- AII $20.32
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- AII N/A
- MRVI 49.60
- Support Level
- AII N/A
- MRVI $2.28
- Resistance Level
- AII N/A
- MRVI $2.47
- Average True Range (ATR)
- AII 0.00
- MRVI 0.14
- MACD
- AII 0.00
- MRVI -0.01
- Stochastic Oscillator
- AII 0.00
- MRVI 27.45
About AII American Integrity Insurance Group Inc. Common Stock
American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.